A promising risk loci for sporadic Alzheimer’s disease (AD), Bridging Integrator 1 (BIN1), is thought to operate through the tau pathology pathway.
Objective:
We examine BIN1 risk for a moderating role with vascular health (pulse pressure; PP) and sex in predictions of episodic memory trajectories in asymptomatic aging adults.
Methods:
The sample included 623 participants (Baseline Mean age = 70.1; 66.8% female) covering a 44-year longitudinal band (53–97 years). With an established memory latent variable arrayed as individualized trajectories, we applied Mplus 8.5 to determine the best fitting longitudinal growth model. Main analyses were conducted in three sequential phases to investigate: 1) memory trajectory prediction by PP, 2) moderation by BIN1 genetic risk, and 3) stratification by sex.
Results:
We first confirmed that good vascular health (lower PP) was associated with higher memory level and shallower decline and males were more severely affected by worsening PP in both memory performance and longitudinal decline. Second, the PP prediction of memory trajectories was significant for BIN1 C/C and C/T carriers but not for persons with the highest AD risk (T/T homozygotes). Third, when further stratified by sex, the BIN1 moderation of memory prediction by PP was selective for females.
Conclusion:
We observed a novel interaction whereby BIN1 (linked with tauopathy in AD) and sex sequentially moderated a benchmark PP prediction of differential memory decline in asymptomatic aging. This multi-modal biomarker interaction approach, disaggregated by sex, can be an effective method for enhancing precision of AD genetic risk assessment.
LoweVJ, WisteHJ, SenjemML, WeigandSD, TherneauTM, BoeveBF, JosephsKA, FangP, PandeyMK, MurrayME, KantarciK, JonesDT, VemuriP, Graff-RadfordJ, SchwarzCG, MachuldaMM, MielkeMM, RobertsRO, KnopmanDS, PetersenRC, JackCRJr (2018) Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia. Brain141, 271–287.
3.
PetersR, BoothA, RockwoodK, PetersJ, D’EsteC, AnsteyKJ (2019) Combining modifiable risk factors and risk of dementia: A systematic review and meta-analysis. BMJ Open9, e022846.
4.
AnsteyKJ, EeN, EramudugollaR, JaggerC, PetersR (2019) A systematic review of meta-analyses that evaluate risk factors for dementia to evaluate the quantity, quality, and global representativeness of evidence. J Alzheimers Dis70, S165–S186.
HampelH, VergalloA, PerryG, ListaS, Alzheimer Precision Medicine Initiative (2019) The Alzheimer precision medicine initiative. J Alzheimers Dis68, 1–24.
7.
DixonRA, LachmanME (2019) Risk and protective factors in cognitive aging: Advances in assessment, prevention, and promotion of alternative pathways. In The Aging Brain: Functional Adaptation Across Adulthood,
Samanez-LarkinGR, ed. APA Books, Washington, DC, pp. 217–263.
8.
FrisoniGB, MolinuevoJL, AltomareD, CarreraE, BarkhofF, BerkhofJ, DelrieuJ, DuboisB, KivipeltoM, NordbergA, SchottJM, van der FlierWM, VellasB, JessenF, ScheltensP, RitchieC (2020) Precision prevention of Alzheimer’s and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimers Dement16, 1457–1468.
9.
McFallGP, BäckmanL, DixonRA (2019) Nuances in Alzheimer’s genetic risk reveal differential predictions of non-demented memory aging trajectories: Selective patterns by APOE genotype and sex. Curr Alzheimer Res16, 302–315.
PiersRJ, LiuY, AngTFA, TaoQ, AuR, QiuWQ (2021) Association between elevated depressive symptoms and cognitive function moderated by APOE4 status: Framingham Offspring Study. J Alzheimers Dis80, 1269–1279.
12.
SapkotaS, RamirezJ, StussDT, MasellisM, BlackSE (2018) Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and women. Alzheimers Res Ther10, 89.
13.
AlmeidaJFF, Dos SantosLR, TrancozoM, de PaulaF (2018) Updated meta-analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 variants in Alzheimer’s disease. J Mol Neurosci64, 471–477.
14.
HuX, PickeringE, LiuYC, HallS, FournierH, KatzE, DechairoB, JohnS, Van EerdeweghP, SoaresH, Alzheimer’s Disease Neuroimaging Initiative (2011) Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer’s disease. PLoS One6, e16616.
15.
ZhangDF, XuM, BiR, YaoYG (2019) Genetic analyses of Alzheimer’s disease in China: Achievements and perspectives. ACS Chem Neurosci10, 890–901.
16.
MuñozSS, GarnerB, OoiL (2019) Understanding the role of ApoE fragments in Alzheimer’s disease. Neurochem Res44, 1297–1305.
17.
SimsR, HillM, WilliamsJ (2020) The multiplex model of the genetics of Alzheimer’s disease. Nat Neurosci23, 311–322.
18.
van der LeeSJ, WoltersFJ, IkramMK, HofmanA, IkramMA, AminN, van DuijnCM (2018) The effect of APOE and other common genetic variants on the onset of Alzheimer’s disease and dementia: A community-based cohort study. Lancet Neurol17, 434–444.
19.
KarchCM, GoateAM (2015) Alzheimer’s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry77, 43–51.
ZhuJ, LiuX, YinH, GaoY, YuH (2021) Convergent lines of evidence support BIN1 as a risk gene of Alzheimer’s disease. Hum Genomics15, 9.
23.
LambertJC, Ibrahim-VerbaasCA, HaroldD, NajAC, SimsR, BellenguezC, DeStafanoAL, BisJC, BeechamGW, Grenier-BoleyB, et al. (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet45, 1452–1458.
24.
FranzmeierN, OssenkoppeleR, BrendelM, RubinskiA, SmithR, KumarA, Mattsson-CarlgrenN, StrandbergO, DueringM, BuergerK, DichgansM, HanssonO, EwersM, Alzheimer’s Disease Neuroimaging Initiative, the Swedish BioFINDER study (2022) The BIN1 rs744373 Alzheimer’s disease risk SNP is associated with faster Aβ-associated tau accumulation and cognitive decline. Alzheimers Dement18, 103–115.
25.
BadhwarA, McFallGP, SapkotaS, BlackSE, ChertkowH, DuchesneS, MasellisM, LiL, DixonRA, BellecP (2020) A multiomics approach to heterogeneity in Alzheimer’s disease: Focused review and roadmap. Brain143, 1315–1331.
26.
GaoP, YeL, ChengH, LiH (2021) The mechanistic role of Bridging Integrator 1 (BIN1) in Alzheimer’s disease. Cell Mol Neurobiol41, 1431–1440.
AndoK, HoubenS, HomaM, de FisenneMA, PotierMC, ErneuxC, BrionJP, LeroyK (2020) Alzheimer’s disease: Tau pathology and dysfunction of endocytosis. Front Mol Neurosci13, 583755.
29.
HongTT, SmythJW, ChuKY, VoganJM, FongTS, JensenBC, FangK, HalushkaMK, RussellSD, ColecraftH, HoopesCW, OcorrK, ChiNC, ShawRM (2012) BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes. Heart Rhythm9, 812–820.
30.
CalafateS, FlavinW, VerstrekenP, MoecharsD (2016) Loss of Bin1 promotes the propagation of tau pathology. Cell Rep17, 931–940.
31.
TakedaS (2019) Tau propagation as a diagnostic and therapeutic target for dementia: Potentials and unanswered questions. Front Neurosci13, 1274.
32.
Ramos Dos SantosL, BelcavelloL, CamporezD, Iamonde Maciel de MagalhaesC, ZandonadeE, Lirio MorelatoR, Imbroisi Valle ErreraF, Drumond LouroI, Do Carmo Pimentel BatitucciM, de PaulaF (2016) Association study of the BIN1 and IL-6 genes on Alzheimer’s disease. Neurosci Lett614, 65–69.
33.
FerenczB, LaukkaEJ, WelmerAK, KalpouzosG, AnglemanS, KellerL, GraffC, LovdenM, BäckmanL (2014) The benefits of staying active in old age: Physical activity counteracts the negative influence of PICALM, BIN1, and CLU risk alleles on episodic memory functioning. Psychol Aging29, 440–449.
34.
LiX, ZhangY, ChenX, YuanH, WangZ, WangG, ZhangK, LiuH (2021) Association of gene polymorphisms in APOE and BIN1 with dementia of Alzheimer’s type susceptibility in Chinese Han population. Front Psychiatry12, 753909.
TierneyMC, CurtisAF, ChertkowH, RylettRJ (2017) Integrating sex and gender into neurodegeneration research: A six-component strategy. Alzheimers Dement3, 660–667.
37.
SteppanJ, BarodkaV, BerkowitzDE, NyhanD (2011) Vascular stiffness and increased pulse pressure in the aging cardiovascular system. Cardiol Res Pract2011, 263585.
38.
de MontgolfierO, Thorin-TrescasesN, ThorinE (2020) Pathological continuum from the rise in pulse pressure to impaired neurovascular coupling and cognitive decline. Am J Hypertens33, 375–390.
39.
LevinRA, CarnegieMH, CelermajerDS (2020) Pulse pressure: An emerging therapeutic target for dementia. Front Neurosci14, 669.
40.
ReasET, LaughlinGA, HaglerDJJr., LeeRR, DaleAM, McEvoyLK (2021) Age and sex differences in the associations of pulse pressure with white matter and subcortical microstructure. Hypertension77, 938–947.
41.
QiuC, WinbladB, ViitanenM, FratiglioniL (2003) Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: A community-based, longitudinal study. Stroke34, 594–599.
42.
SingerJ, TrollorJN, BauneBT, SachdevPS, SmithE (2014) Arterial stiffness, the brain and cognition: A systematic review. Ageing Res Rev15, 16–27.
43.
BérardE, BongardV, RuidavetsJB, AmarJ, FerrieresJ (2013) Pulse wave velocity, pulse pressure and number of carotid or femoral plaques improve prediction of cardiovascular death in a population at low risk. J Hum Hypertens27, 529–534.
RazN, RodrigueKM, HaackeEM (2007) Brain aging and its modifiers: Insights from in vivo neuromorphometry and susceptibility weighted imaging. Ann N Y Acad Sci1097, 84–93.
47.
RazN, DahleCL, RodrigueKM, KennedyKM, LandS (2011) Effects of age, genes, and pulse pressure on executive functions in healthy adults. Neurobiol Aging32, 1124–1137.
48.
SapkotaS, McFallGP, MasellisM, DixonRA, BlackSE (2022) Differential cognitive decline in Alzheimer’s disease is predicted by changes in ventricular size but moderated by Apolipoprotein E and pulse pressure. J Alzheimers Dis85, 545–560.
49.
McFallGP, SapkotaS, McDermottKL, DixonRA (2016) Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults. Neurobiol Aging42, 91–100.
50.
McFallGP, WiebeSA, VergoteD, WestawayD, JhamandasJ, BäckmanL, DixonRA (2015) ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ɛ2 carriers. Neuropsychology29, 388–401.
51.
DixonRA, de FriasCM (2004) The Victoria Longitudinal Study: From characterizing cognitive aging to illustrating changes in memory compensation. Aging Neuropsychol Cogn11, 346–376.
52.
DixonRA, SmallBJ, MacDonaldSW, McArdleJJ (2012) Yes, memory declines with aging–but when, how, and why? In Memory Aging: Current Issues and Future Directions,
Naveh-BenjaminM,
OhtaN, eds. Psychology Press, New York, NY, pp. 325–347.
53.
LittleT (2013) Longitudinal Structural Equation Modeling, Guilford Press, New York, NY.
54.
KlineR (2011) Convergence of structural equation modeling and multilevel modeling. In The SAGE Handbook of Innovation in Social Research Methods. SAGE Publications Ltd, pp. 562–589.
55.
McFallGP, McDermottKL, DixonRA (2019) Modifiable risk factors discriminate memory trajectories in non-demented aging: Precision factors and targets for promoting healthier brain aging and preventing dementia. J Alzheimers Dis70, S101–S118.
56.
MuthénLK,
MuthénBO (1999-2017) Mplus.Muthén & Muthén, Los Angeles, CA.
57.
DrouinSM, McFallGP, DixonRA (2020) In multiple facets of subjective memory decline sex moderates memory predictions. Alzheimers Dement12, e12089.
58.
SapkotaS, BäckmanL, DixonRA (2017) Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle. Neurobiol Aging52, 81–89.
59.
PutnickDL, BornsteinMH (2016) Measurement invariance conventions and reporting: The state of the art and future directions for psychological research. Dev Rev41, 71–90.
60.
GrahamJW (2009) Missing data analysis: Making it work in the real world. Annu Rev Psychol60, 549–576.
61.
SmallBJ, DixonRA, McArdleJJ (2011) Tracking cognition-health changes from 55 to 95 years of age. J Gerontol B Psychol Sci Soc Sci66 (Suppl 1), i153–i161.
CrottiA, SaitHR, McAvoyKM, EstradaK, ErgunA, SzakS, MarshG, JandreskiL, PetersonM, ReynoldsTL, Dalkilic-LiddleI, CameronA, Cahir-McFarlandE, RansohoffRM (2019) BIN1 favors the spreading of Tau via extracellular vesicles. Sci Rep9, 9477.
64.
HollerCJ, DavisPR, BeckettTL, PlattTL, WebbRL, HeadE, MurphyMP (2014) Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer’s disease brain and correlates with neurofibrillary tangle pathology. J Alzheimers Dis42, 1221–1227.
65.
FranzmeierN, RubinskiA, NeitzelJ, EwersM, Alzheimer’s Disease Neuroimaging Initiative (2019) The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory. Nat Commun10, 1766.
66.
Tort-MerinoA, OlivesJ, LeonM, PenalozaC, ValechN, Santos-SantosMA, CamaraE, Gronholm-NymanP, Martinez-LageP, ForteaJ, MolinuevoJL, Sanchez-ValleR, LaineM, Rodriguez-FornellsA, RamiL (2019) Tau protein is associated with longitudinal memory decline in cognitively healthy subjects with normal Alzheimer’s disease cerebrospinal fluid biomarker levels. J Alzheimers Dis70, 211–225.
67.
ClarkAL, WeigandAJ, ThomasKR, SoldersSK, Delano-WoodL, BondiMW, BernierRA, SundermannEE, BanksSJ, BangenKJ, Alzheimer’s Disease Neuroimaging Initiative (2021) Elevated inflammatory markers and arterial stiffening exacerbate tau but not amyloid pathology in older adults with mild cognitive impairment. J Alzheimers Dis80, 1451–1463.
68.
HuH, MengL, BiYL, ZhangW, XuW, ShenXN, OuYN, MaYH, DongQ, TanL, YuJT (2022) Tau pathologies mediate the association of blood pressure with cognitive impairment in adults without dementia: The CABLE study. Alzheimers Dement18, 53–64.
69.
MikkolaTS, GisslerM, MerikukkaM, TuomikoskiP, YlikorkalaO (2013) Sex differences in age-related cardiovascular mortality. PLoS One8, e63347.
70.
DahleCL, JacobsBS, RazN (2009) Aging, vascular risk, and cognition: Blood glucose, pulse pressure, and cognitive performance in healthy adults. Psychol Aging24, 154–162.
SubramaniapillaiS, AlmeyA, Natasha RajahM, EinsteinG (2021) Sex and gender differences in cognitive and brain reserve: Implications for Alzheimer’s disease in women. Front Neuroendocrinol60, 100879.
73.
DigmaLA, MadsenJR, RissmanRA, JacobsDM, BrewerJB, BanksSJ, Alzheimer’s Disease Neuroimaging Initiative (2020) Women can bear a bigger burden: Ante- and post-mortem evidence for reserve in the face of tau. Brain Commun2, fcaa025.
74.
BanksSJ, AndrewsMJ, DigmaL, MadsenJ, ReasET, CaldwellJZK, McEvoyLK, FanCC, DaleAM, BrewerJB, Alzheimer’s Disease Neuroimaging Initiative (2021) Sex differences in Alzheimer’s disease: Do differences in tau explain the verbal memory gap?Neurobiol Aging107, 70–77.
75.
McFallGP, WiebeSA, VergoteD, JhamandasJ, WestawayD, DixonRA (2014) IDE (rs6583817) polymorphism and pulse pressure are independently and interactively associated with level and change in executive function in older adults. Psychol Aging29, 418–430.
76.
TagaM, PetyukVA, WhiteC, MarshG, MaY, KleinHU, ConnorSM, KroshilinaA, YungCJ, KhairallahA, OlahM, SchneiderJ, KarhohsK, CarpenterAE, RansohoffR, BennettDA, CrottiA, BradshawEM, De JagerPL (2020) BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: Neuronal and astrocyte BIN1 are implicated in tau pathology. Mol Neurodegener15, 44.
77.
GreenbaumL, Ravona-SpringerR, LubitzI, SchmeidlerJ, CooperI, SanoM, SilvermanJM, HeymannA, BeeriMS (2016) Potential contribution of the Alzheimer’s disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly. Eur Neuropsychopharmacol26, 787–795.
78.
SajiN, TobaK, SakuraiT (2016) Cerebral small vessel disease and arterial stiffness: Tsunami effect in the brain?Pulse3, 182–189.
79.
SapkotaS, DixonRA (2018) A network of genetic effects on non-demented cognitive aging: Alzheimer’s Genetic Risk (CLU+CR1+PICALM) intensifies cognitive aging genetic risk (COMT+BDNF) selectively for APOE ɛ4 carriers. J Alzheimers Dis62, 887–900.
80.
Reuter-LorenzPA, FestiniSB, JantzTK (2021) Executive functions and neurocognitive aging. In Handbook of the Psychology of Aging,
SchaieKW,
WillisSL, eds. Academic Press, pp. 67–81.
81.
SundermannE, MakiPM, RubinLH, LiptonRB, LandauS, BiegonA (2016) Female advantage in verbal memory: Evidence of sex-specific cognitive reserve. Neurology87, 1916–1924.
82.
SundermannEE, BiegonA, RubinLH, LiptonRB, LandauS, MakiPM, Alzheimer’s Disease Neuroimaging Initiative (2017) Does the female advantage in verbal memory contribute to underestimating Alzheimer’s disease pathology in women versus men?J Alzheimers Dis56, 947–957.
